Claudine Bruck is Director of Annovis Bio, Inc.. Currently has a direct ownership of 7,567 shares of ANVS, which is worth approximately $66,059. The most recent transaction as insider was on Nov 20, 2023, when has been sold 1,000 shares (Common Stock) at a price of $6.07 per share, resulting in proceeds of $6,070. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.57K
0% 3M change
15.23% 12M change
Total Value Held $66,059

Claudine Bruck Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 20 2023
BUY
Grant, award, or other acquisition
$6,070 $6.07 p/Share
1,000 Added 11.67%
7,567 Common Stock
Apr 07 2023
BUY
Grant, award, or other acquisition
$6,305 $12.61 p/Share
500 Added 7.08%
6,567 Common Stock
Oct 11 2021
BUY
Open market or private purchase
$5,006 $27.66 p/Share
181 Added 2.9%
6,067 Common Stock

Also insider at

NAVB
NAVIDEA BIOPHARMACEUTICALS, INC. Healthcare
CB

Claudine Bruck

Director
Dublin, OH

Track Institutional and Insider Activities on ANVS

Follow Annovis Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANVS shares.

Notify only if

Insider Trading

Get notified when an Annovis Bio, Inc. insider buys or sells ANVS shares.

Notify only if

News

Receive news related to Annovis Bio, Inc.

Track Activities on ANVS